v3.25.2
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
May 31, 2025
Nov. 30, 2024
Current Assets    
Cash $ 49,122 $ 311,000
Short-term investment 605,037 (0)
Prepaid expenses 80,972 15,000
Total Current Assets 735,131 326,000
Deferred offering costs 190,000
Prepaid expenses 57,920
Investments held in Trust Account 83,492,945
Total Assets 84,285,996 516,000
Current Liabilities    
Accounts payable and accrued expenses 260,315 1,166
Promissory note – related party 500,000
Total Current Liabilities 260,315 501,166
Deferred underwriting fee payable 3,312,000
Total Liabilities 3,572,315 501,166
Commitments and Contingencies – see Note 6    
Ordinary shares subject to possible redemption, 8,280,000 shares and 0 shares at redemption value of $10.08 and $0 per share as of May 31, 2025 and November 30, 2024, respectively 83,492,945
Shareholders’ (Deficit) Equity    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,129,900 shares and 2,898,000(1) issued and outstanding, respectively as of May 31, 2025 and November 30, 2024 (excluding 8,280,000 and 0 shares subject to possible redemption as of May 31, 2025 and November 30, 2024, respectively) 313 290
Additional paid-in capital 24,710
Accumulated deficit (2,779,577) (10,166)
Total Shareholders’ (Deficit) Equity (2,779,264) 14,834 [1]
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity $ 84,285,996 $ 516,000
[1] Ordinary shares have been retroactively restated to reflect two amendments to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares initially from 1,725,000 to 2,415,000, then to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).